Skip to content
10-Q

Quarterly Report

DICE THERAPEUTICS, INC.

0000950170-22-023833

← back to feed
Filed
Nov 9, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Oct 31, 2022 47.67M sh
Shares Diluted Q3 2022 · Sep 30, 2022 37.48M sh
Shares Diluted Q3 2022 · Sep 30, 2022 37.37M sh
Shares Diluted Q3 2022 · Sep 30, 2021 7.55M sh
Shares Diluted Q3 2022 · Sep 30, 2021 4.04M sh
Capex Q3 2022 · Sep 30, 2022 $1.8M
Capex Q3 2022 · Sep 30, 2021 $522K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$46.43M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$24.88M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $48.27M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $115.83M
Cash And Equivalents Q3 2022 · Sep 30, 2021 $311.61M
Stockholders Equity Q3 2022 · Sep 30, 2022 $261.11M
Stockholders Equity Q3 2022 · Jun 30, 2022 $277.94M
Stockholders Equity Q3 2022 · Mar 31, 2022 $295.17M
Stockholders Equity Q3 2022 · Dec 31, 2021 $312.95M
Stockholders Equity Q3 2022 · Sep 30, 2021 $327.52M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$67.89M
Stockholders Equity Q3 2022 · Mar 31, 2021 −$60.87M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$53.15M
Current Liabilities Q3 2022 · Sep 30, 2022 $11.67M
Current Liabilities Q3 2022 · Dec 31, 2021 $10.88M
Total Liabilities Q3 2022 · Sep 30, 2022 $23.88M
Total Liabilities Q3 2022 · Dec 31, 2021 $12.81M
Current Assets Q3 2022 · Sep 30, 2022 $267.84M
Current Assets Q3 2022 · Dec 31, 2021 $323.91M
Total Assets Q3 2022 · Sep 30, 2022 $284.99M
Total Assets Q3 2022 · Dec 31, 2021 $325.75M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.55
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.62
Eps Diluted Q3 2022 · Sep 30, 2021 −$2.30
Eps Diluted Q3 2022 · Sep 30, 2021 −$8.12
Eps Basic Q3 2022 · Sep 30, 2022 −$0.55
Eps Basic Q3 2022 · Sep 30, 2022 −$1.62
Eps Basic Q3 2022 · Sep 30, 2021 −$2.30
Eps Basic Q3 2022 · Sep 30, 2021 −$8.12
Sga Expense Q3 2022 · Sep 30, 2022 $6.44M
Sga Expense Q3 2022 · Sep 30, 2022 $19.3M
Sga Expense Q3 2022 · Sep 30, 2021 $4.44M
Sga Expense Q3 2022 · Sep 30, 2021 $8.23M
Rd Expense Q3 2022 · Sep 30, 2022 $14.73M
Rd Expense Q3 2022 · Sep 30, 2022 $42.47M
Rd Expense Q3 2022 · Sep 30, 2021 $11.69M
Rd Expense Q3 2022 · Sep 30, 2021 $24.29M
Net Income Q3 2022 · Sep 30, 2022 −$20.55M
Net Income Q3 2022 · Sep 30, 2022 −$60.66M
Net Income Q3 2022 · Jun 30, 2022 −$21.52M
Net Income Q3 2022 · Mar 31, 2022 −$18.59M
Net Income Q3 2022 · Sep 30, 2021 −$17.34M
Net Income Q3 2022 · Sep 30, 2021 −$32.76M
Net Income Q3 2022 · Jun 30, 2021 −$7.36M
Net Income Q3 2022 · Mar 31, 2021 −$8.07M
Operating Income Q3 2022 · Sep 30, 2022 −$21.17M
Operating Income Q3 2022 · Sep 30, 2022 −$61.77M
Operating Income Q3 2022 · Sep 30, 2021 −$16.13M
Operating Income Q3 2022 · Sep 30, 2021 −$31.39M
Long Term Debt Q3 2022 · Dec 31, 2021 $1.92M
Short Term Debt Q3 2022 · Dec 31, 2021 $480K
Revenue Q3 2022 · Sep 30, 2021 $1.13M